CYPRESS SEMICONDUCTOR CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

ON A GAAP BASIS

(In thousands, except per-share data)

(Unaudited)

Three Months Ended

October 2, 2016

July 3, 2016

Revenues

$

523,845

$

450,127

Costs and expenses:

Cost of revenues

325,225

291,349

Research and development

95,411

70,171

Selling, general and administrative

92,179

82,490

Amortization of intangible assets

54,849

32,605

Impairment related to assets held for sale

35,259

—

(Gain) related to investment in Deca Technologies

(112,774)

—

Goodwill impairment charge

—

488,504

Total costs and expenses

490,149

965,119

Operating income (loss)

33,696

(514,992)

Interest and other expense, net

(16,924)

(7,316)

Income (loss) before income taxes and non-controlling interest

16,772

(522,308)

Income tax (provision) benefit

(3,304)

5,221

Equity in net loss of equity method investees

(4,233)

(2,568)

Net income (loss)

9,235

(519,655)

Net loss attributable to non-controlling interests

176

381

Net income (loss) attributable to Cypress

$

9,411

$

(519,274)

Net income (loss) per share attributable to Cypress:

Basic

$

0.03

$

(1.65)

Diluted

$

0.03

$

(1.65)

Cash dividend declared per share

$

0.11

$

0.11

Shares used in net income (loss) per share calculation:

Basic

321,276

314,305

Diluted

343,718

314,305